Home › Funds › Paradigm Biocapital Advisors LP › ORKA

Paradigm Biocapital Advisors LP position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Paradigm Biocapital Advisors LP reported holding 2,493,507 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$207.7M, representing 4.13% of its reported portfolio and ranking #8 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed ORKA holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.49M sh
Reported value held$207.68M
Portfolio Weight4.13%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's ORKA position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in ORKA in Q3 2024 at 719,660 shares (US$17.6M). The position peaked in Q3 2026 at 2,493,507 shares, worth US$207.7M. Across 6 filings, Paradigm Biocapital Advisors LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,493,507 shares valued at US$207.7M — an increase of 348,981 shares quarter over quarter.. Notable position changes include a 36% increase in Q1 2026 (shares rose 94% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 719.66K $17.64M New
Q4 2024 819.66K $15.89M Add
Q4 2025 1.71M $51.84M New
Q1 2026 2.32M $113.81M Add
Q2 2026 2.14M $204.09M Reduce
Q3 2026 2.49M $207.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 76 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$261.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held ORKA?

Paradigm Biocapital Advisors LP has disclosed ORKA holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

What is Paradigm Biocapital Advisors LP's current position in ORKA?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 2.49M shares of ORKA (ORUKA THERAPEUTICS INC), valued at $207.68M, representing 4.13% of its reported portfolio and ranking #8.

Has Paradigm Biocapital Advisors LP been buying or selling ORKA?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP increased its position in ORKA. The position peaked in Q3 2026 at 2.49M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 76 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.